APO Research
Talk to an analyst

APO RESEARCH · REPORT

Morpholine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Morpholine Market Outlook and Growth Opportunities 2026

20 December 2025190 pages

Choose your research edition.

Industry ResearchMorpholine Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Morpholine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Morpholine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Morpholine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Morpholine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Morpholine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Morpholine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Morpholine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Morpholine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Morpholine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Morpholine market include APL (IN), Balaji Amines (IN), Basf (DE), FUYUAN (CN), Huntsman (US), Liaoyuan (CN), Nippon Nyukazai (JP), Sinochem (CN) and Anhui Haoyuan (CN), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Morpholine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Morpholine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Morpholine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Morpholine market size, projected growth trends, production technologies, key applications, and end-use industries.

Morpholine Segment by Company

APL (IN)

Balaji Amines (IN)

Basf (DE)

FUYUAN (CN)

Huntsman (US)

Liaoyuan (CN)

Nippon Nyukazai (JP)

Sinochem (CN)

Anhui Haoyuan (CN)

Morpholine Segment by Type

Ethanolamine method

Two glycol method

Morpholine Segment by Application

Optical polishing AIDS

Corrosion inhibitor

Morpholine derivatives

Rubber additives

Other

Morpholine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Morpholine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Morpholine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Morpholine significant trends, drivers, influence factors in global and regions.

6. To analyze Morpholine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morpholine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Morpholine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morpholine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Morpholine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Morpholine industry.

Chapter 3: Detailed analysis of Morpholine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Morpholine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Morpholine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Morpholine Industry Trends Table 2. Morpholine Industry Drivers Table 3. Morpholine Industry Opportunities and Challenges Table 4. Morpholine Industry Restraints Table 5. Global Morpholine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Morpholine Revenue Share by Company (2021-2026) Table 7. Global Morpholine Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Morpholine Sales Volume Share by Company (2021-2026) Table 9. Global Morpholine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Morpholine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Morpholine Key Company Manufacturing Base & Headquarters Table 12. Global Morpholine Company, Product Type & Application Table 13. Global Morpholine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Morpholine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Ethanolamine method Table 18. Significant Companies of Two glycol method Table 19. Global Morpholine Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Morpholine Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Morpholine Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Morpholine Sales Volume Share by Type (2021-2026) Table 23. Global Morpholine Sales Volume Share by Type (2027-2032) Table 24. Global Morpholine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Morpholine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Morpholine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Morpholine Sales Value Share by Type (2021-2026) Table 28. Global Morpholine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Optical polishing AIDS Table 30. Significant Companies of Corrosion inhibitor Table 31. Significant Companies of Morpholine derivatives Table 32. Significant Companies of Rubber additives Table 33. Significant Companies of Other Table 34. Global Morpholine Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 35. Global Morpholine Sales Volume by Application (2021-2026) & (W Units) Table 36. Global Morpholine Sales Volume by Application (2027-2032) & (W Units) Table 37. Global Morpholine Sales Volume Share by Application (2021-2026) Table 38. Global Morpholine Sales Volume Share by Application (2027-2032) Table 39. Global Morpholine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Morpholine Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Morpholine Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Morpholine Sales Value Share by Application (2021-2026) Table 43. Global Morpholine Sales Value Share by Application (2027-2032) Table 44. Global Morpholine Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 45. Global Morpholine Sales by Region (2021-2026) & (W Units) Table 46. Global Morpholine Sales Market Share by Region (2021-2026) Table 47. Global Morpholine Sales by Region (2027-2032) & (W Units) Table 48. Global Morpholine Sales Market Share by Region (2027-2032) Table 49. Global Morpholine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Morpholine Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Morpholine Sales Value Share by Region (2021-2026) Table 52. Global Morpholine Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Morpholine Sales Value Share by Region (2027-2032) Table 54. Global Morpholine Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Morpholine Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Morpholine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. Global Morpholine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Morpholine Sales by Country (2021-2026) & (W Units) Table 59. Global Morpholine Sales Market Share by Country (2021-2026) Table 60. Global Morpholine Sales by Country (2027-2032) & (W Units) Table 61. Global Morpholine Sales Market Share by Country (2027-2032) Table 62. Global Morpholine Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Morpholine Sales Value Market Share by Country (2021-2026) Table 64. Global Morpholine Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Morpholine Sales Value Market Share by Country (2027-2032) Table 66. APL (IN) Company Information Table 67. APL (IN) Business Overview Table 68. APL (IN) Morpholine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. APL (IN) Morpholine Product Portfolio Table 70. APL (IN) Recent Development Table 71. Balaji Amines (IN) Company Information Table 72. Balaji Amines (IN) Business Overview Table 73. Balaji Amines (IN) Morpholine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Balaji Amines (IN) Morpholine Product Portfolio Table 75. Balaji Amines (IN) Recent Development Table 76. Basf (DE) Company Information Table 77. Basf (DE) Business Overview Table 78. Basf (DE) Morpholine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Basf (DE) Morpholine Product Portfolio Table 80. Basf (DE) Recent Development Table 81. FUYUAN (CN) Company Information Table 82. FUYUAN (CN) Business Overview Table 83. FUYUAN (CN) Morpholine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. FUYUAN (CN) Morpholine Product Portfolio Table 85. FUYUAN (CN) Recent Development Table 86. Huntsman (US) Company Information Table 87. Huntsman (US) Business Overview Table 88. Huntsman (US) Morpholine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Huntsman (US) Morpholine Product Portfolio Table 90. Huntsman (US) Recent Development Table 91. Liaoyuan (CN) Company Information Table 92. Liaoyuan (CN) Business Overview Table 93. Liaoyuan (CN) Morpholine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Liaoyuan (CN) Morpholine Product Portfolio Table 95. Liaoyuan (CN) Recent Development Table 96. Nippon Nyukazai (JP) Company Information Table 97. Nippon Nyukazai (JP) Business Overview Table 98. Nippon Nyukazai (JP) Morpholine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Nippon Nyukazai (JP) Morpholine Product Portfolio Table 100. Nippon Nyukazai (JP) Recent Development Table 101. Sinochem (CN) Company Information Table 102. Sinochem (CN) Business Overview Table 103. Sinochem (CN) Morpholine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sinochem (CN) Morpholine Product Portfolio Table 105. Sinochem (CN) Recent Development Table 106. Anhui Haoyuan (CN) Company Information Table 107. Anhui Haoyuan (CN) Business Overview Table 108. Anhui Haoyuan (CN) Morpholine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Anhui Haoyuan (CN) Morpholine Product Portfolio Table 110. Anhui Haoyuan (CN) Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Morpholine Distributors List Table 114. Morpholine Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Morpholine Product Image Figure 2. Global Morpholine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Morpholine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Morpholine Sales (2021-2032) & (W Units) Figure 5. Global Morpholine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Morpholine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Ethanolamine method Image Figure 10. Two glycol method Image Figure 11. Global Morpholine Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Morpholine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Morpholine Sales Volume Share by Type (2021-2032) Figure 14. Global Morpholine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Morpholine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Morpholine Sales Value Share by Type (2021-2032) Figure 17. Optical polishing AIDS Image Figure 18. Corrosion inhibitor Image Figure 19. Morpholine derivatives Image Figure 20. Rubber additives Image Figure 21. Other Image Figure 22. Global Morpholine Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Morpholine Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Morpholine Sales Volume Share by Application (2021-2032) Figure 25. Global Morpholine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Morpholine Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Morpholine Sales Value Share by Application (2021-2032) Figure 28. Global Morpholine Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 29. Global Morpholine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Morpholine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Morpholine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Morpholine Sales Value (2021-2032) & (US$ Million) Figure 33. North America Morpholine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Morpholine Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Morpholine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Morpholine Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Morpholine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Morpholine Sales Value (2021-2032) & (US$ Million) Figure 39. South America Morpholine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Morpholine Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Morpholine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Morpholine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Morpholine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Morpholine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Morpholine Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Morpholine Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Ethanolamine method
  • Two glycol method
Applications
  • Optical polishing AIDS
  • Corrosion inhibitor
  • Morpholine derivatives
  • Rubber additives
  • Other
Companies covered
  • APL (IN)
  • Balaji Amines (IN)
  • Basf (DE)
  • FUYUAN (CN)
  • Huntsman (US)
  • Liaoyuan (CN)
  • Nippon Nyukazai (JP)
  • Sinochem (CN)
  • Anhui Haoyuan (CN)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Morpholine Sales Value (2021-2032)
  4. 1.2.2 Global Morpholine Sales Volume (2021-2032)
  5. 1.2.3 Global Morpholine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Morpholine Market Dynamics
  1. 2.1 Morpholine Industry Trends
  2. 2.2 Morpholine Industry Drivers
  3. 2.3 Morpholine Industry Opportunities and Challenges
  4. 2.4 Morpholine Industry Restraints
3 Morpholine Market by Company
  1. 3.1 Global Morpholine Company Revenue Ranking in 2025
  2. 3.2 Global Morpholine Revenue by Company (2021-2026)
  3. 3.3 Global Morpholine Sales Volume by Company (2021-2026)
  4. 3.4 Global Morpholine Average Price by Company (2021-2026)
  5. 3.5 Global Morpholine Company Ranking (2024-2026)
  6. 3.6 Global Morpholine Company Manufacturing Base and Headquarters
  7. 3.7 Global Morpholine Company Product Type and Application
  8. 3.8 Global Morpholine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Morpholine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Morpholine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Morpholine Market by Type
  1. 4.1 Morpholine Type Introduction
  2. 4.1.1 Ethanolamine method
  3. 4.1.2 Two glycol method
  4. 4.2 Global Morpholine Sales Volume by Type
  5. 4.2.1 Global Morpholine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Morpholine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Morpholine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Morpholine Sales Value by Type
  9. 4.3.1 Global Morpholine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Morpholine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Morpholine Sales Value Share by Type (2021-2032)
5 Morpholine Market by Application
  1. 5.1 Morpholine Application Introduction
  2. 5.1.1 Optical polishing AIDS
  3. 5.1.2 Corrosion inhibitor
  4. 5.1.3 Morpholine derivatives
  5. 5.1.4 Rubber additives
  6. 5.1.5 Other
  7. 5.2 Global Morpholine Sales Volume by Application
  8. 5.2.1 Global Morpholine Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Morpholine Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Morpholine Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Morpholine Sales Value by Application
  12. 5.3.1 Global Morpholine Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Morpholine Sales Value by Application (2021-2032)
  14. 5.3.3 Global Morpholine Sales Value Share by Application (2021-2032)
6 Morpholine Regional Sales and Value Analysis
  1. 6.1 Global Morpholine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Morpholine Sales by Region (2021-2032)
  3. 6.2.1 Global Morpholine Sales by Region: 2021-2026
  4. 6.2.2 Global Morpholine Sales by Region (2027-2032)
  5. 6.3 Global Morpholine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Morpholine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Morpholine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Morpholine Sales Value by Region (2027-2032)
  9. 6.5 Global Morpholine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Morpholine Sales Value (2021-2032)
  12. 6.6.2 North America Morpholine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Morpholine Sales Value (2021-2032)
  15. 6.7.2 Europe Morpholine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Morpholine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Morpholine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Morpholine Sales Value (2021-2032)
  21. 6.9.2 South America Morpholine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Morpholine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Morpholine Sales Value Share by Country, 2025 VS 2032
7 Morpholine Country-level Sales and Value Analysis
  1. 7.1 Global Morpholine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Morpholine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Morpholine Sales by Country (2021-2032)
  4. 7.3.1 Global Morpholine Sales by Country (2021-2026)
  5. 7.3.2 Global Morpholine Sales by Country (2027-2032)
  6. 7.4 Global Morpholine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Morpholine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Morpholine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Morpholine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Morpholine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Morpholine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Morpholine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Morpholine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Morpholine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Morpholine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Morpholine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Morpholine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Morpholine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Morpholine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Morpholine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Morpholine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Morpholine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Morpholine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Morpholine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Morpholine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Morpholine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Morpholine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Morpholine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Morpholine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Morpholine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Morpholine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Morpholine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Morpholine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Morpholine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Morpholine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Morpholine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Morpholine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Morpholine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Morpholine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Morpholine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Morpholine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Morpholine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Morpholine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Morpholine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Morpholine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Morpholine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Morpholine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Morpholine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Morpholine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Morpholine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Morpholine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Morpholine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Morpholine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Morpholine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Morpholine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Morpholine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Morpholine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Morpholine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Morpholine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Morpholine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Morpholine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Morpholine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Morpholine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Morpholine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Morpholine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Morpholine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Morpholine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Morpholine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Morpholine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Morpholine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Morpholine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Morpholine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Morpholine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Morpholine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Morpholine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Morpholine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Morpholine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Morpholine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Morpholine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Morpholine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Morpholine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Morpholine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Morpholine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Morpholine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Morpholine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Morpholine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Morpholine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Morpholine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Morpholine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Morpholine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Morpholine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Morpholine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 APL (IN)
  2. 8.1.1 APL (IN) Company Information
  3. 8.1.2 APL (IN) Business Overview
  4. 8.1.3 APL (IN) Morpholine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 APL (IN) Morpholine Product Portfolio
  6. 8.1.5 APL (IN) Recent Developments
  7. 8.2 Balaji Amines (IN)
  8. 8.2.1 Balaji Amines (IN) Company Information
  9. 8.2.2 Balaji Amines (IN) Business Overview
  10. 8.2.3 Balaji Amines (IN) Morpholine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Balaji Amines (IN) Morpholine Product Portfolio
  12. 8.2.5 Balaji Amines (IN) Recent Developments
  13. 8.3 Basf (DE)
  14. 8.3.1 Basf (DE) Company Information
  15. 8.3.2 Basf (DE) Business Overview
  16. 8.3.3 Basf (DE) Morpholine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Basf (DE) Morpholine Product Portfolio
  18. 8.3.5 Basf (DE) Recent Developments
  19. 8.4 FUYUAN (CN)
  20. 8.4.1 FUYUAN (CN) Company Information
  21. 8.4.2 FUYUAN (CN) Business Overview
  22. 8.4.3 FUYUAN (CN) Morpholine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 FUYUAN (CN) Morpholine Product Portfolio
  24. 8.4.5 FUYUAN (CN) Recent Developments
  25. 8.5 Huntsman (US)
  26. 8.5.1 Huntsman (US) Company Information
  27. 8.5.2 Huntsman (US) Business Overview
  28. 8.5.3 Huntsman (US) Morpholine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Huntsman (US) Morpholine Product Portfolio
  30. 8.5.5 Huntsman (US) Recent Developments
  31. 8.6 Liaoyuan (CN)
  32. 8.6.1 Liaoyuan (CN) Company Information
  33. 8.6.2 Liaoyuan (CN) Business Overview
  34. 8.6.3 Liaoyuan (CN) Morpholine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Liaoyuan (CN) Morpholine Product Portfolio
  36. 8.6.5 Liaoyuan (CN) Recent Developments
  37. 8.7 Nippon Nyukazai (JP)
  38. 8.7.1 Nippon Nyukazai (JP) Company Information
  39. 8.7.2 Nippon Nyukazai (JP) Business Overview
  40. 8.7.3 Nippon Nyukazai (JP) Morpholine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nippon Nyukazai (JP) Morpholine Product Portfolio
  42. 8.7.5 Nippon Nyukazai (JP) Recent Developments
  43. 8.8 Sinochem (CN)
  44. 8.8.1 Sinochem (CN) Company Information
  45. 8.8.2 Sinochem (CN) Business Overview
  46. 8.8.3 Sinochem (CN) Morpholine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sinochem (CN) Morpholine Product Portfolio
  48. 8.8.5 Sinochem (CN) Recent Developments
  49. 8.9 Anhui Haoyuan (CN)
  50. 8.9.1 Anhui Haoyuan (CN) Company Information
  51. 8.9.2 Anhui Haoyuan (CN) Business Overview
  52. 8.9.3 Anhui Haoyuan (CN) Morpholine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Anhui Haoyuan (CN) Morpholine Product Portfolio
  54. 8.9.5 Anhui Haoyuan (CN) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Morpholine Value Chain Analysis
  2. 9.1.1 Morpholine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Morpholine Sales Mode & Process
  6. 9.2 Morpholine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Morpholine Distributors
  9. 9.2.3 Morpholine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst